VERRICA PHARMACEUTICALS INC's ticker is VRCA and the CUSIP is 92511W108. A total of 50 filers reported holding VERRICA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.73 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $250,808 | -37.3% | 64,558 | -6.9% | 0.00% | 0.0% |
| Q2 2023 | $400,196 | +30.7% | 69,358 | +47.3% | 0.00% | 0.0% |
| Q1 2023 | $306,105 | +119.0% | 47,093 | -7.3% | 0.00% | – |
| Q4 2022 | $139,755 | -2.3% | 50,820 | +3.9% | 0.00% | – |
| Q3 2022 | $143,000 | +37.5% | 48,893 | -9.9% | 0.00% | – |
| Q2 2022 | $104,000 | -43.5% | 54,267 | +232.6% | 0.00% | – |
| Q2 2021 | $184,000 | -7.1% | 16,316 | +24.5% | 0.00% | -100.0% |
| Q1 2021 | $198,000 | +2.1% | 13,100 | -26.1% | 0.00% | -50.0% |
| Q1 2020 | $194,000 | -70.5% | 17,729 | -57.1% | 0.00% | 0.0% |
| Q4 2019 | $657,000 | +133.0% | 41,345 | +138.1% | 0.00% | +100.0% |
| Q3 2018 | $282,000 | – | 17,364 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Altium Capital Management LP | 256,244 | $3,203,000 | 0.84% |
| Perceptive Advisors | 3,610,412 | $45,130,000 | 0.66% |
| Orbimed Advisors | 1,479,733 | $18,497,000 | 0.20% |
| Fosun International Ltd | 282,408 | $3,530,000 | 0.18% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 728,236 | $9,103,000 | 0.14% |
| SteelPeak Wealth, LLC | 133,161 | $1,665,000 | 0.11% |
| HighVista Strategies LLC | 10,944 | $137,000 | 0.09% |
| Capital Investment Advisory Services, LLC | 15,125 | $189,000 | 0.02% |
| MML INVESTORS SERVICES, LLC | 44,875 | $561,000 | 0.00% |
| BECK MACK & OLIVER LLC | 10,000 | $125,000 | 0.00% |